drugset / Trial / NCT01478854

Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide

NCT01478854

NaSingle-groupOpen-labelTreatment

Summary

The long term goal of this research is to establish whether NPC sparing RT techniques improve neurocognitive outcomes compared to conventional RT for brain tumors. If the proposed study demonstrates that NPC sparing RT is not associated with increased LR in the spared regions of the brain compared to conventional RT, it will ideally serve as the foundation for a future multi-institutional randomized controlled trial comparing neurocognitive outcomes in patients treated with NPC-sparing RT versus conventional radiation therapy.

Timeline

Start
2011-12-27
Primary completion
2018-04-25
Completion
2018-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule

Indications